Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
28.84
+0.06 (0.21%)
At close: Oct 29, 2026, 4:00 PM EDT
28.20
-0.64 (-2.22%)
After-hours: Oct 29, 2026, 7:56 PM EDT
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.88 billion as of October 29, 2026. It is the 5,255th most valuable company in the world and the 1,544th biggest in the United States. Its market cap has increased by 10.95% in one year.
Market Cap
2.88B
Enterprise Value
1.98B
1-Year Change
10.95%
Global Rank
Country Rank
#1,544 United States
Category
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.88B, an increase of 778.69%. That is a compound annual growth rate of 38.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.88B | 5.34% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.65B |
| Arcus Biosciences | 2.61B |
| MBX Biosciences | 2.55B |
| ADMA Biologics | 2.50B |
| SELLAS Life Sciences Group | 2.46B |
| NewAmsterdam Pharma Company | 2.45B |
| Recursion Pharmaceuticals | 2.42B |
| Celldex Therapeutics | 2.37B |